CpG-55.2, another TLR9 agonist, and imidazoquinolin, a TLR7/8 agonist, have also been formulated as adjuvants in EUA COVID-19 vaccines [39, 126, 136, 221, 322]. Here, TLR9 is linked to COVID-19.